GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Core C – Immunophenotyping Core

$198,096
Martin John Romeo · Medical University Of South Carolina · P01 · FY2023 · CA

A promising small molecule for pancreatic cancer therapy

$198,064
Arun K Sharma · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2019 · CA

Education and Outreach Unit

$198,039
Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA

Nanoengineering Core

$198,028
Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2013 · CA

Proteomic Pathways for Pancreatic Cancer Stem Cells

$198,025
David M. Lubman · University Of Michigan At Ann Arbor · R21 · FY2009 · CA

Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites

$198,018
Matthew Everett Griffin · University Of California-Irvine · K22 · FY2023 · CA

Enhancement of Cancer Therapy Using Ketogenic Diets

$198,000
Douglas Robert Spitz · University Of Iowa · R21 · FY2009 · CA

Novel Suppressors of Pancreatic Cancer

$198,000
Dawn E Quelle · University Of Iowa · R21 · FY2009 · CA

Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer

$198,000
Joseph J Cullen · University Of Iowa · R21 · FY2010 · CA

Cetuximab Therapy of Pancreatic Cancer: Immune Modulation with IL-21

$198,000
William E. Carson · Ohio State University · R21 · FY2009 · CA

Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis

$198,000
Min Li · University Of Texas Hlth Sci Ctr Houston · R21 · FY2010 · CA

Functionalized Lipid Carriers for Nucleic-Acid and Drug Therapeutics

$197,966
Cyrus R Safinya · University Of California Santa Barbara · R01 · FY2020 · GM

ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER

$197,840
William E Fisher · Baylor College Of Medicine · U01 · FY2019 · DK

P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer

$197,835
Keith R Johnson · University Of Nebraska Medical Center · P50 · FY2012 · CA

CD: Tissue Core

$197,778
Wilma Lingle · Mayo Clinic Rochester · P50 · FY2009 · CA

Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma

$197,708
Tad H Koch · University Of Colorado · R21 · FY2011 · CA

Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer

$197,693
Douglas V Faller · Boston University Medical Campus · R21 · FY2014 · CA

Core C - Integrated Quantitative Science (IQS)

$197,626
Michael R Kosorok · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA

Tissue and Pathology Resources

$197,589
Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2011 · CA

Supramolecular matrix materials for prostate cancer cell biology

$197,500
Donald James Vander Griend · University Of Chicago · R21 · FY2017 · CA

Contrast Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

$197,472
Ji-Bin Liu · Thomas Jefferson University · R21 · FY2019 · CA

RNases for understanding the origin of new gene function

$197,437
University Of Michigan At Ann Arbor · R01 · FY2003 · GM

TBEL Project 3

$197,437
Laura Delong Wood · New York University School Of Medicine · U54 · FY2025 · CA

TBEL Project 2

$197,437
Anirban Maitra · New York University School Of Medicine · U54 · FY2025 · CA

TBEL Admin Core

$197,437
Anirban Maitra · New York University School Of Medicine · U54 · FY2025 · CA